Opinion: PAs need a new name, but ‘physician associate’ won’t cut it. Here’s a better idea
I’m standing over an operating table, excising a skin cancer from the forehead of an…
Category: Medicine
Opinion: The agony of finding decent health care for my young-adult daughter with Down syndrome
Several years ago, a local artist asked if she could paint my younger daughter, then…
After outcry, UnitedHealthcare softens prior authorization policy for colonoscopies
After weeks of protest from physician organizations and patients, UnitedHealthcare has put a controversial new…
Black men were likely underdiagnosed with lung problems because of bias in software, study suggests
NEW YORK (AP) — Racial bias built into a common medical test for lung function…
Listen: Fake medical devices, real cancer drugs, & curious Ozempic effects
Why are fake medical devices more lucrative than real ones? Is Ozempic a neurological treatment?…
Nuance’s mysterious pricing, speedier digital health evidence reviews, and new breakthrough devices
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Insurance alone didn’t guarantee adherence to Ozempic, study finds
Having insurance coverage alone doesn’t guarantee that people can afford or would be willing to…
U.S. births in 2022 didn’t return to pre-pandemic levels
U.S. births were flat last year, as the nation saw fewer babies born than it…
.jpg)
Medicare holds firm on Alzheimer’s drug coverage policy
WASHINGTON — Despite pressure from Congress and advocates, Medicare isn’t changing its coverage plan for…
STAT+: Pharmalittle: Coherus undercuts AbbVie with discounted Humira; FDA approves second RSV vaccine
Good morning, everyone. Damian Garde here, filling in for Ed Silverman on the back half…
STAT+: Tempus launches an AI ‘assistant’ for thousands of oncologists
Tempus, a company that combines DNA sequencing for cancer with artificial intelligence, said Thursday that…
STAT+: Coherus works with Mark Cuban to sell biosimilar Humira at steep discounts
In a bold move, Coherus BioSciences plans to sell a biosimilar version of Humira —…
STAT+: Debt ceiling deal could mean cancer, disease research cuts, advocates warn
WASHINGTON — Researchers and health care advocates are warning that the debt ceiling deal would…
STAT+: Republicans want to crack down on pricey health regulations, but there are major loopholes
WASHINGTON — At first glance, the debt ceiling deal that Republicans struck with the White…
Opinion: The DEA needs to officially allow telehealth prescribing for opioid use disorder
The statistics are dismal, though they bear repeating: 81% of overdose deaths in the U.S….
Opinion: Doctors think “advocate” is a dirty word. But it’s our ethical responsibility
Last Thursday, after 15 hours of deliberation, the Indiana State Licensing board ruled that our…
Hospitals want to buy doctors’ happiness with Nuance’s AI scribe. What they’re paying varies
Microsoft-owned Nuance Communications sells its AI medical scribe platform to health care providers on a…
FDA approves Pfizer’s RSV vaccine for older adults
The Food and Drug Administration approved a second vaccine to protect older adults against RSV…
.jpg)
STAT+: CVS warns PBM reforms ‘could lead to higher costs’
As Congress considers wide-ranging reforms to pharmacy benefit managers, a top executive at CVS Health,…
House Republicans demand career scientist explain pathogen research
WASHINGTON — House Republicans are ratcheting up pressure on federal agencies’ pandemic response with an…
STAT+: Pharmalittle: Appeals court rules Purdue can shield Sacklers from lawsuits; chemo shortage blamed on drugmakers’ lack of investment
Hey there. STAT reporter Andrew Joseph here welcoming you to Wednesday’s edition of Pharmalittle, with…
Opinion: Newly diagnosed cancer patients need help navigating the system
“Hey, I’m sorry to bother you, but I could really use your advice on something.”…
Opinion: Listen: Ezekiel Emanuel explains why cancer patients shouldn’t pay out-of-pocket costs
The high cost of cancer treatment in the U.S. is literally killing people. “Over a…
‘A target on my back’: New survey shows racism is a huge problem in nursing
A family nurse practitioner in New York City, Jose M. Maria has come to expect…
Sacklers win appeal that shields them from opioid lawsuits, clearing way for bankruptcy settlement
A federal appeals court ruled Tuesday Purdue Pharma can shield its owners — members of…
Sen. Elizabeth Warren probes abortion access amid states’ patchwork plans
WASHINGTON – Sen. Elizabeth Warren (D-Mass.) is launching a fresh round of questioning on states’…
STAT+: Pharmalittle: Pfizer touts study data for hemophilia drug; former Novartis execs cleared of bribery in Greece
Good morning, everyone, and how are you today? We are doing find, thank you, especially…
STAT+: European regulatory panel weighing against approval of Amylyx’s ALS therapy, company says
LONDON — A European regulatory panel has taken a negative view of whether an ALS…
Opinion: More hospitals are offering child care. But they shouldn’t have to
Since the pandemic began, thousands of child care locations have closed, exacerbating an already acute…
STAT+: Lured by a bigger payday, a medical device maker sold fake plastic parts. Many were implanted in chronic pain patients
Stimwave’s pitch was alluring. As a startup tackling chronic pain with nerve-stimulating devices, it promised…
Opinion: More young people should be getting their cholesterol tested and taking statins
For busy primary care physicians like me, an annual physical with a 27-year-old male is…
STAT+: Neuralink can now study its brain implant in humans, but it’s still catching up to its peers
Neuralink can now study its brain implant in humans after securing a go-ahead from the…
Omada tackles obesity drugs, Boston Scientific nixes deal, and Microsoft health exec on GPT
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Some hoped a new oral vaccine would solve all the polio campaign’s problems. Reality is settling in
When a new and hoped-to-be safer oral polio vaccine started to make its way into…
STAT+: Pharmalittle: EMA urges revoking authorization for Novartis sickle cell drug; U.K. tries to placate pharma execs
And so, another working week will soon draw to a close. Not a moment too…
Science finally figured out how to make effective RSV vaccines. Will seniors care?
The world has waited decades for vaccines to protect older adults against RSV. One, made…
Texas wants to wean trans youth off meds in a ‘safe and medically appropriate’ way. Doctors say that’s impossible
In a wave of anti-LGBTQ legislation, 19 U.S. states thus far have banned at least…
Opinion: STAT+: An overlooked way to make participants in clinical trials look more like America
A recent report from the National Academies of Sciences, Engineering and Medicine (of which one…
STAT+: U.K. unveils $800 million package to bolster life sciences amid concern over biopharma investments
LONDON — The U.K. government on Thursday unveiled an $800 million package to bolster the…
STAT+: Bristol drug reduces reliance on transfusions for people with chronic blood disorder
In a study reported Thursday, a medicine from Bristol Myers Squibb nearly doubled the treatment…
STAT+: Gilead and Teva defend antitrust claims that prices for HIV medicines were unfairly kept high
Amid concern that HIV prevention pills are not being widely taken by those at highest…
Listen: ChatGPT in medicine, a boom in weight loss pills, & Sarepta at the FDA
Can AI diagnose a disease? Are Wegovy’s days numbered? And what makes AI hallucinate? We…
STAT+: Illumina shareholders elect one Icahn ally to board, as company holds off broader challenge
Shareholders in the DNA-sequencing firm Illumina on Thursday voted to replace the company’s chairman with…
STAT+: Pharmalittle: FDA approvals will stop if U.S. defaults on its debts; DEA failed to punish wholesaler blamed in opioid crisis
Oh, what a beautiful morning. Yes, this is a cliché, but the saying is apt,…
Opinion: Adopting the term ‘preaddiction’ would be a serious mistake
The National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism recently proposed…
How Medicare’s Aduhelm decision revived old questions about new drugs
This article is adapted from the latest STAT Report: Decoding Medicare: 10 key coverage decisions…
Opinion: Opportunistic CT: There’s gold in them there images
More than 80 million CT scans are performed each year in the U.S. alone. In…
STAT+: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals
WASHINGTON — At a waterfront concert in one of this city’s swankiest neighborhoods, rappers Busta…
Ketamine is comparable to ECT for patients with treatment-resistant depression, study shows
When seriously depressed patients don’t respond to antidepressants, the alternatives are limited. Now a new…
STAT+: Matt Eyles, CEO of America’s Health Insurance Plans, to depart
Matt Eyles, CEO of America’s Health Insurance Plans, is leaving by this October, the lobbying…